Cargando…

Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations

Antibody–drug conjugates (ADCs) represent a novel and evolving class of antineoplastic agents, constituted by monoclonal antibody linked to biologically active drugs, delivering cytotoxic compounds at the tumor site, reducing the likelihood of systemic exposure and toxicity. They are generally well...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Arienzo, Andrea, Verrazzo, Annarita, Pagliuca, Martina, Napolitano, Fabiana, Parola, Sara, Viggiani, Martina, Caputo, Roberta, Puglisi, Fabio, Giuliano, Mario, Del Mastro, Lucia, Arpino, Grazia, De Laurentiis, Michelino, Montemurro, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404866/ https://www.ncbi.nlm.nih.gov/pubmed/37554126 http://dx.doi.org/10.1016/j.eclinm.2023.102113

Ejemplares similares

Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-negative breast cancer: a case report
por: Caputo, Roberta, et al.
Publicado: (2023)

Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice
por: Buono, Giuseppe, et al.
Publicado: (2022)

Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests
por: Saponaro, Mariarosaria, et al.
Publicado: (2022)

CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
por: Schettini, Francesco, et al.
Publicado: (2018)

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project
por: Pelizzari, Giacomo, et al.
Publicado: (2018)

Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approach
por: Fabi, Alessandra, et al.
Publicado: (2022)

Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study
por: Di Maio, Massimo, et al.
Publicado: (2023)

Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic review
por: Di Lauro, V., et al.
Publicado: (2022)

Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis
por: De Angelis, Carmine, et al.
Publicado: (2017)

Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer
por: Puglisi, Fabio, et al.
Publicado: (2021)

Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis
por: Schettini, Francesco, et al.
Publicado: (2021)

T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study
por: Schettini, F., et al.
Publicado: (2021)

Emetogenicity of Antibody-Drug Conjugates (ADCs) in Solid Tumors with a Focus on Trastuzumab Deruxtecan: Insights from an Italian Expert Panel
por: Bianchini, Giampaolo, et al.
Publicado: (2022)

Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer
por: Buonaiuto, Roberto, et al.
Publicado: (2022)

Prevalence of Sarcopenia in Women with Breast Cancer
por: Morlino, Delia, et al.
Publicado: (2022)

1st Scientific International Conference on CBRNe
por: Malizia, Andrea, et al.
Publicado: (2018)

Uncertainty Analysis in the Calibration of an Emission Tomography System for Quantitative Imaging
por: D'Arienzo, Marco, et al.
Publicado: (2017)

Assessment of the SARS-CoV-2 basic reproduction number, R(0), based on the early phase of COVID-19 outbreak in Italy
por: D'Arienzo, Marco, et al.
Publicado: (2020)

The role of taxanes in triple-negative breast cancer: literature review
por: Mustacchi, Giorgio, et al.
Publicado: (2015)

Rare tumours of the breast
por: Esposito, Emanuela, et al.
Publicado: (2019)

Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy
por: Arpino, Grazia, et al.
Publicado: (2015)

A case of bilateral luxatio erecta
por: Camarda, Lawrence, et al.
Publicado: (2008)

A rare case of peri-implant distal radius fracture()
por: Stramazzo, Leonardo, et al.
Publicado: (2020)

Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives
por: Agostinetto, Elisa, et al.
Publicado: (2022)

Peri-Implant Distal Radius Fracture: Proposal of a New Classification
por: Stramazzo, Leonardo, et al.
Publicado: (2022)

Preliminary report in treatment of proximal humeral fracture with closed reduction and DOS external fixation System: a multicentric study
por: Scaravilli, Gabriele, et al.
Publicado: (2022)

Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies
por: Lambertini, Matteo, et al.
Publicado: (2023)

Aneurysmal Bone Cyst of the Pelvis in Children and Adolescents: Effectiveness of Surgical Treatment with Curettage, Cryotherapy and Bone Grafting
por: Andreani, Lorenzo, et al.
Publicado: (2023)

What’s the resolutive surgery for pseudo-ainhum in Vohwinkel syndrome? A case report and review of the literature
por: Rovere, Giuseppe, et al.
Publicado: (2021)

Male Breast Cancer: From Molecular Genetics to Clinical Management
por: Pensabene, Matilde, et al.
Publicado: (2022)

Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series
por: Schettini, Francesco, et al.
Publicado: (2020)

Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications
por: De Placido, S, et al.
Publicado: (2017)

Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives
por: Cocco, Stefania, et al.
Publicado: (2020)

How to Optimise Extended Adjuvant Treatment with Neratinib for Patients with Early HER2+ Breast Cancer
por: Untch, Michael, et al.
Publicado: (2021)

Considerations on the RF-System
por: Puglisi, M
Publicado: (1987)

Corrigendum to ‘Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)’: [ESMO Open Volume 6, Issue 2, April 2021, 100054]
por: De Angelis, C., et al.
Publicado: (2021)

Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study
por: Buono, Giuseppe, et al.
Publicado: (2017)

Augmentation of tibial plateau fractures with an injectable bone substitute: CERAMENT™. Three year follow-up from a prospective study
por: Iundusi, Riccardo, et al.
Publicado: (2015)

Hereditary Multiple Exostoses: Current Insights
por: D’Arienzo, Antonio, et al.
Publicado: (2019)

Disseminated and Central Nervous System Vaccine-Strain Herpes Zoster Infection in a Teenager With Crohn’s Disease on Maintenance Adalimumab Therapy
por: D’Arienzo, David, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e0l5ibqic9m4l17smu8qmfp2mq